Back
Xeris Biopharma Holdings Stock Price Chart
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Buy
70
XERS
Xeris Biopharma Holdings
Last Price:
$3.48
Seasonality Move:
-18.08%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight buying pressure.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.39 | Buy |
| 20-day SMA: | 3.44 | Buy |
| 50-day SMA: | 3.26 | Buy |
| 200-day SMA: | 2.56 | Buy |
| 8-day EMA: | 3.43 | Buy |
| 20-day EMA: | 3.39 | Buy |
| 50-day EMA: | 3.25 | Buy |
| 200-day EMA: | 2.76 | Buy |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 54.75 | Buy |
| Chaikin Money Flow: | 47338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.17 - 3.57) | Buy |
| Bollinger Bands (100): | (2.66 - 3.34) | Buy |
Xeris Biopharma Holdings Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 3.47 while XERS 8-day simple moving average is 3.39, which is a Buy signal.
-
The stock price of XERS is 3.47 while Xeris Biopharma Holdings 20-day SMA is 3.44, which makes it a Buy.
-
Xeris Biopharma Holdings 50-day simple moving average is 3.26 while XERS share price is 3.47, making it a Buy technically.
-
XERS stock price is 3.47 and Xeris Biopharma Holdings 200-day simple moving average is 2.56, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
70
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a BuyThe current Xeris Biopharma Holdings [XERS] share price is $3.47. The Score for XERS is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
517.3M
Price in USD:
3.47
Share Volume:
520.7K
Xeris Biopharma Holdings 52-Week Range
52-Week High:
3.87
52-Week Low:
1.69
Buy
70
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?The Xeris Biopharma Holdings stock price is 3.47 USD today.
-
Will XERS stock go up or go down?Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Xeris Biopharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 3.47 while XERS 8-day exponential moving average is 3.43, which is a Buy signal.
-
The stock price of XERS is 3.47 while Xeris Biopharma Holdings 20-day EMA is 3.39, which makes it a Buy.
-
Xeris Biopharma Holdings 50-day exponential moving average is 3.25 while XERS share price is 3.47, making it a Buy technically.
-
XERS stock price is 3.47 and Xeris Biopharma Holdings 200-day simple moving average is 2.76, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.05 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
-
XERS Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Xeris Biopharma Holdings is a Buy
-
Xeris Biopharma Holdings Relative Strength Index (RSI) is 54.75, which suggest Xeris Biopharma Holdings is overbought
-
The Bollinger Bands (25) for Xeris Biopharma Holdings is (3.17 - 3.57), which suggest Xeris Biopharma Holdings is a Buy
-
The Bollinger Bands (100) for Xeris Biopharma Holdings is (2.66 - 3.34), which suggest Xeris Biopharma Holdings is a Buy
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.